|
Volumn 45, Issue 1, 2002, Pages 115-126
|
7-Substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: A study on the importance of modifications at the side chain on the activity and solubility
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 FURAN 2 YL 7H PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDIN 5 YLAMINE;
4 [3 (5 AMINO 2 FURAN 2 YLPYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDIN 7 YL)ETHYL] N HYDROXYBENZAMIDINE;
5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE;
5 AMINO 2 (2 FURYL) 7 (3 PHENYLPROPYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE;
7 [3 (4 AMINOPHENYL)ETHYL] 2 FURAN 2 YL 7H PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDIN 5 YLAMINE;
7 [3 (4 AMINOPHENYL)PROPYL] 2 FURAN 2 YL 7H PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDIN 5 YLAMINE;
[5 [3 (5 AMINO 2 FURAN 2 YLPYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDIN 7 YL)PROPYL] 2 HYDROXYMETHYLBENZO[1,3]DIOXOL 2 YL]METHANOL;
ADENOSINE A2A RECEPTOR;
ADENOSINE A2A RECEPTOR ANTAGONIST;
ADENOSINE A2B RECEPTOR;
ADENOSINE A3 RECEPTOR;
AMINE;
FURAN;
PHENYL GROUP;
PYRAZOLE;
PYRIMIDINE DERIVATIVE;
UNCLASSIFIED DRUG;
WATER;
ANIMAL CELL;
ARTICLE;
CHEMICAL MODIFICATION;
CONTROLLED STUDY;
DRUG RECEPTOR BINDING;
DRUG SELECTIVITY;
DRUG SOLUBILITY;
DRUG SYNTHESIS;
HYDROPHILICITY;
NONHUMAN;
PARKINSON DISEASE;
RECEPTOR AFFINITY;
STRUCTURE ACTIVITY RELATION;
BINDING, COMPETITIVE;
CHROMATOGRAPHY, THIN LAYER;
DRUG DESIGN;
FURANS;
HUMANS;
PYRIMIDINES;
RADIOLIGAND ASSAY;
RECEPTOR, ADENOSINE A2A;
RECEPTORS, PURINERGIC P1;
SOLUBILITY;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 0037011899
PISSN: 00222623
EISSN: None
Source Type: Journal
DOI: 10.1021/jm010924c Document Type: Article |
Times cited : (114)
|
References (32)
|